Literature DB >> 8191954

Recent developments in hepatitis delta virus research.

D W Lazinski1, J M Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8191954     DOI： 10.1016/s0065-3527(08)60049-4

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN： 0065-3527            Impact factor:   9.937


× No keyword cloud information.
  15 in total

1.  Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen.

Authors:  Brendan O'Malley; David W Lazinski
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Intracellular cleavage and ligation of hepatitis delta virus genomic RNA: regulation of ribozyme activity by cis-acting sequences and host factors.

Authors:  D W Lazinski; J M Taylor
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

3.  Use of a prenylation inhibitor as a novel antiviral agent.

Authors:  J S Glenn; J C Marsters; H B Greenberg
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

4.  Efficient hepatitis delta virus RNA replication in avian cells requires a permissive factor(s) from mammalian cells.

Authors:  Y T Liu; R Brazas; D Ganem
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Development of a novel system to study hepatitis delta virus genome replication.

Authors:  Jinhong Chang; Severin O Gudima; Chi Tarn; Xingcao Nie; John M Taylor
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication.

Authors:  L E Modahl; M M Lai
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates.

Authors:  T B Fu; J Taylor
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

Authors:  Bruno B Bordier; Junko Ohkanda; Ping Liu; So-Young Lee; F H Salazar; Patricia L Marion; Kazuo Ohashi; Leonard Meuse; Mark A Kay; John L Casey; Said M Sebti; Andrew D Hamilton; Jeffrey S Glenn
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging.

Authors:  D W Lazinski; J M Taylor
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.